Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
---|
03/23/2006 | US20060063818 Hydantoin derivatives and deren verwendung als tace inhibitoren |
03/23/2006 | US20060063811 Pyridinalkyl-aminoalkyl-ih-indole derivatives having an inhibitory action on 5-ht and serotonin reuptake as antidepressants and anxiolytics |
03/23/2006 | US20060063809 Tri-substituted heteroaryls and methods of making and using the same |
03/23/2006 | US20060063807 Low molecular weight peptidomimetic growth hormone secretagogues |
03/23/2006 | US20060063796 Pyrazoles as inhibitors of tumor necrosis factor |
03/23/2006 | US20060063783 Sulphonylpiperidine derivatives containing an alkenyl or alkynyl moiety for use as matrix metalloproteinase inhibitors |
03/23/2006 | US20060063782 3-Hetero arylmethoxy ! pyridines and their analogues as p38 map kinase inhibitors |
03/23/2006 | US20060063771 CCR5 antagonists useful for treating AIDS |
03/23/2006 | US20060063770 Nitrogenous heterocyclic compounds |
03/23/2006 | US20060063759 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease |
03/23/2006 | US20060063758 Neuropeptide Y antagonist; antiarthritc agents; cardiovascular disorders; antidiabetic agents; kidney diseases; eating disorders; obesity |
03/23/2006 | US20060063741 Compounds useful as pesticides |
03/23/2006 | DE112004000832T5 Lichtemittierende Polymerzusammensetzung Light-emitting polymer composition |
03/23/2006 | DE102004036349A1 Substituierte 3-Phenylpiperidin-Derivate Substituted 3-phenyl piperidine derivatives |
03/23/2006 | CA2787378A1 Method and apparatus for producing oxidized compound |
03/23/2006 | CA2581144A1 Novel pyridinone derivatives and their use as positive allosteric modulators of mglur2-receptors |
03/23/2006 | CA2580409A1 Triazole derivative or salt thereof |
03/23/2006 | CA2580033A1 Imidazole compound |
03/23/2006 | CA2580020A1 Aryl spirolactam cgrp receptor antagonists |
03/23/2006 | CA2579847A1 Bicyclic anilide spirolactam cgrp receptor antagonists |
03/23/2006 | CA2579665A1 Method and apparatus for producing oxidized compound |
03/23/2006 | CA2579501A1 Nitrogenous heterocyclic derivative and medicine containing the same as an active ingredient |
03/23/2006 | CA2579143A1 Vanilloid receptor ligands and their use in treatments |
03/23/2006 | CA2577181A1 Heteroaroyl-substituted serine amides utilized as herbicides |
03/23/2006 | CA2568832A1 Indole derivatives as antiviral agents |
03/22/2006 | EP1637566A1 Cationic diazo compounds, compositions comprising them as direct dye, methods for dyeing keratin fibres and kit |
03/22/2006 | EP1637529A1 Novel piperidin-4-yl-thiazole-carboxamide analogues as inhibitors of T-cell proliferation and uses thereof |
03/22/2006 | EP1637524A1 10-substituted 1-, 4, 7,-tris (carboxymethyl)-1,4,7,10-tetraazacyclo-dodecane derivative for use as contrast agents |
03/22/2006 | EP1636221A2 New azetidine compounds |
03/22/2006 | EP1636216A1 BENZIMIDAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS |
03/22/2006 | EP1636207A1 Substituted piperidine carbamates for use as inhibitors of hormone sensitive lipase |
03/22/2006 | EP1636206A1 Imidazole derivatives as glutmate receptor antagonists |
03/22/2006 | EP1636205A1 Pyridinyl carbamates as hormone-sensitive lipase inhibitors |
03/22/2006 | EP1636197A1 Novel 3-substituted-1,4-benzodiazepines |
03/22/2006 | EP1636195A1 Quinazolines and pyrido[3,4-d]pyrimidines as receptor tyrosine kinase inhibitors |
03/22/2006 | EP1636193A1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
03/22/2006 | EP1636189A1 1-aryl-4-(aryloxycarbonyl)-piperazine derivatives for use as inhibitors of hormone sensitive lipase |
03/22/2006 | EP1636187A1 Substituted piperazine carbamates for use as inhibitors of hormone sensitive lipase |
03/22/2006 | EP1636182A2 Prodrugs of mitotic kinesin inhibitors |
03/22/2006 | EP1636181A1 Substituted 3-alkyl and 3-alkenyl azetidine derivatives |
03/22/2006 | EP1635835A1 2-aminopyrimidine derivatives as raf kinase inhibitors |
03/22/2006 | EP1635829A1 8-(3-biaryl)phenylquinoline phosphodiesterase-4-inhibitors |
03/22/2006 | EP1635821A2 4-bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (phenyl)amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases |
03/22/2006 | EP1474417B1 Processes for preparing losartan and losartan potassium |
03/22/2006 | EP1472221B1 Substituted indoles, method for production and use thereof for the inhibition of pain |
03/22/2006 | EP1322635B1 Farnesyl transferase inhibiting quinoline and quinazoline derivatives as farnesyl transferase inhibitors |
03/22/2006 | EP1309586B1 4-, 5-, 6- and 7-indole derivatives useful for the treatment of cns disorders |
03/22/2006 | EP1140924B1 Piperazine derivatives |
03/22/2006 | EP1140840B1 -g(v)-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
03/22/2006 | EP1107963B1 Alkynyl-substituted quinolin-2-one derivatives useful as anticancer agents |
03/22/2006 | CN1751052A Therapeutic agents |
03/22/2006 | CN1751047A Triazole compounds useful in therapy |
03/22/2006 | CN1751039A Pyridine derivatives as fungicidal compounds |
03/22/2006 | CN1751038A Substituted aryl and heteroaryl derivatives as modulators of glucose metabolism and the prophylaxis and treatment of disorders thereof |
03/22/2006 | CN1751028A Non-nucleoside reverse transcriptase inhibitors |
03/22/2006 | CN1751025A Diamine derivatives |
03/22/2006 | CN1751024A Nitrogenous heterocyclic derivative and organic electroluminescent element employing the same |
03/22/2006 | CN1751023A Piperidine-benzenesulfonamide derivatives |
03/22/2006 | CN1750824A 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-alkoxy-3-quinolinecarbonitriles for the treatment of ischemic injury |
03/22/2006 | CN1750823A Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
03/22/2006 | CN1749255A 1,2,3,6-tetrahydro phthal-imide compound and their preparation and use |
03/22/2006 | CN1246318C Process for preparation of imidazole compounds |
03/22/2006 | CN1245979C Preventive or therapeutic drugs for fibrosis containing chymase inhibitors as active ingredient |
03/22/2006 | CN1245978C Preventive or therapeutic drugs for various eosinophilia realated diseases containing chymase inhibitors as active ingredient |
03/21/2006 | US7015327 Anthrapyridone compound containing two phenyl rings substituted by sodium sulfonate groups; excellent in light fastness and water fastness |
03/21/2006 | US7015241 Appetite-stimulating agents and remedies for anorexia |
03/21/2006 | US7015237 Pyridine matrix metalloproteinase inhibitors |
03/21/2006 | US7015235 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
03/21/2006 | US7015233 Fused compounds that inhibit vanilloid subtype 1 (VR1) receptor |
03/21/2006 | US7015229 An antagonist of a corticotropin releasing factor (CRF) receptor, treating central nervous system disorders or anxiety disorders, depression and stress |
03/21/2006 | US7015228 4-amino-2-(2-pyridyl)pyrimidines as microbicidal active substances |
03/21/2006 | US7015220 enzyme inhibitors used as modulators of tyrosine kinase signal transduction and/or as antiproliferative agents; prophylaxis of vision defects, cancer, atherosclerosis, restenosis, metabolic disorders or autoimmune diseases |
03/21/2006 | US7015218 Amide compounds and medicinal use thereof |
03/21/2006 | US7015216 Heteroaryl-β-alanine derivatives as alpha 4 integrin inhibitors |
03/21/2006 | US7015214 Such as 7-chloro-2-cyanoimino-5-(cyclopropylmethyloxy)-1,5-dihydro-5-trifluoromethyl-1,3-benzodiazepine |
03/21/2006 | CA2399358C Pyrrole substituted 2-indolinone protein kinase inhibitors |
03/21/2006 | CA2315220C Integrin receptor antagonists |
03/21/2006 | CA2270887C Methods and compositions for inhibition of angiogenesis |
03/21/2006 | CA2242416C Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same |
03/21/2006 | CA2238816C N-acyl-2-substituted-4-(benzimidazolyl- or imidazopyridinyl-substituted residues)-piperidines as tachykinin antagonists |
03/21/2006 | CA2139112C Novel nicotinic acid esters |
03/21/2006 | CA2134625C Substituted pyridylsalicylaldehyde or -salicylic acid derivatives, their preparation and their use as herbicides |
03/21/2006 | CA2124932C Sex steroid activity inhibitors |
03/16/2006 | WO2006028964A1 Processes for the preparation of substituted 2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolines |
03/16/2006 | WO2006028958A2 Pyridyl inhibitors of hedgehog signalling |
03/16/2006 | WO2006028957A1 4-substituted 4, 6-dialkoxy-cinnoline derivatives as phospodiesterase 10 inhibitors for the treatment of psychiatric or neurological syndroms |
03/16/2006 | WO2006028904A1 Quinazolines useful as modulators of ion channels |
03/16/2006 | WO2006028590A1 1,1,2,2-tetra (hetero) arylethanes or 1,1,2-tri (hetero) aryl-2-heterocyclylethanes as potassium channel inhibitors |
03/16/2006 | WO2006028226A1 Novel imidazolidine derivative and use thereof |
03/16/2006 | WO2006027628A2 Naphthalimide derivatives as antiviral agents |
03/16/2006 | WO2006027211A1 2,4-substituted pyrimidines as cysteine protease inhibitors |
03/16/2006 | WO2006005609A3 Substituted oxindol derivatives and medicaments containing the same |
03/16/2006 | WO2005123680B1 Six-membered heterocycles useful as serine protease inhibitors |
03/16/2006 | WO2005121121A3 Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
03/16/2006 | WO2005113535A3 Pyrazinylmethyl lactam derivatives |
03/16/2006 | WO2005113494A3 Nitrogenated heterocyclic derivatives as protein kinase modulators and use for the treatment of angiogenesis and cancer |
03/16/2006 | WO2005100349A3 Polycyclic pyridines as potassium ion channel modulators |
03/16/2006 | US20060058778 Novel compounds |
03/16/2006 | US20060058570 Radioactive member and method of making |
03/16/2006 | US20060058553 Novel bicyclic hydroxamates as inhibitors of histone deacetylase |